Android app Apple app link

Harmony Biosciences Holdings, Inc. (HRMY) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$27.39
Day's range
$28.61

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
08/05/2026 Truist Financial Danielle Brill $34.00 $39.28   -13.44%
08/04/2026 Oppenheimer Andreas Argyrides $70.00 $38.78   80.51%
06/30/2026 Deutsche Bank David Hoang $36.00 $36.22   -0.61%
02/11/2026 UBS Youn Shim $46.00 $37.93   21.28%
11/24/2025 Oppenheimer Andreas Argyrides $62.00 $34.31   80.71%
07/10/2025 Goldman Sachs Corinne Johnson $33.00 $34.33   -3.87%
10/30/2024 Goldman Sachs Corinne Jenkins $28.00 $41.49   -32.51%
10/10/2024 Mizuho Securities Graig Suvannavejh $52.00 $33.60   54.76%
09/10/2024 UBS Ashwani Verma $56.00 $36.89   51.8%
08/08/2024 Mizuho Securities Graig Suvannavejh $42.00 $33.55   25.19%
06/24/2024 Oppenheimer Francois Brisebois $56.00 $30.39   84.27%
05/01/2024 Needham Ami Fadia $52.00 $30.37   71.22%
04/30/2024 Raymond James Danielle Brill $37.00 $30.91   19.7%
10/14/2022 Jefferies Chris Howerton $61.00 $47.63   28.07%

Harmony Biosciences Holdings Inc FAQ's

Harmony Biosciences Holdings Inc has been rated by research analysts at Deutsche Bank, Truist Financial, UBS, Oppenheimer, Mizuho Securities, H.C. Wainwright in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.